Skip to main content

Table 2 Independent prognostic analysis of the riskScore and clinicopathological factors in BC patient set

From: A novel molecular subtypes and risk model based on inflammatory response-related lncrnas for bladder cancer

Variable

 

Training cohort

Test cohort

Univariate Cox

Multivariate Cox

Univariate Cox

Multivariate Cox

HR

95%CI

p

HR

95%CI

p

HR

95%CI

p

HR

95%CI

p

Age

 

1.028

1.005-1.053

0.019

1.017

0.994-1.040

0.158

1.040

1.018-1.062

<0.001

1.034

1.012-1.057

0.003

Gender

Male/Female

1.188

0.728-1.939

0.491

1.245

0.747-2.075

0.400

0.571

0.362-0.899

0.016

0.589

0.372-0.931

0.023

Smoked

YES/NO

1.323

0.806-2.171

0.268

0.915

0.538-1.554

0.742

1.170

0.706-1.939

0.542

1.162

0.696-1.939

0.566

Stage

I/II/III/IV

2.168

1.585-2.966

<0.001

1.466

1.051-2.045

0.024

1.526

1.179-1.974

0.001

1.361

1.050-1.763

0.020

riskScore

 

2.834

2.263-3.550

<0.001

2.559

2.011-3.256

<0.001

1.573

1.309-1.809

<0.001

1.539

1.239-1.912

<0.001

Back to article page

Hereditas

ISSN: 1601-5223

Contact us